Hanson Mouanoutoua

Hanson Mouanoutoua practices at Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health.

Hanson Mouanoutoua's NPI, 1417489345, was assigned on March 30, 2017. Hanson Mouanoutoua holds Idaho license O-1696.

Hanson Mouanoutoua's primary practice is Kootenai Health, at 2003 Kootenai Health Way, Coeur D Alene, ID 83814 in Kootenai County. The practice phone is (208) 625-4000.

Hanson Mouanoutoua's primary practice is Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health. Hanson Mouanoutoua is also affiliated with Northwest Specialty Hospital. The medical group on file is Kootenai Health. Dmand AI also links Hanson Mouanoutoua to 2 more hospitals, 1 hospital outpatient department and 1 medical group, each named with a free account. Hanson Mouanoutoua's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Hanson Mouanoutoua practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Hanson Mouanoutoua's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Hanson Mouanoutoua is licensed in Idaho.

CMS data shows 1,031 Medicare services from Hanson Mouanoutoua across 6 procedure codes in 2024, for 595 Medicare patients. Medicare paid $92,108 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 595 Medicare patients who saw Hanson Mouanoutoua in 2024. The largest group is 75 to 84, with 226 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hanson Mouanoutoua's median patient age at 75, with 50% women.

In 2024, Hanson Mouanoutoua wrote 444 Medicare Part D claims for 199 patients. 91% of them were for generic drugs. CMS names the drug for 201 of them, across 9 drugs with 11 or more claims each, at $5,516 in total drug cost. In 2023, CMS named 230 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Hanson Mouanoutoua for performance year 2024, reported through an alternative payment model (APM). Hanson Mouanoutoua accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Hanson Mouanoutoua in 2022. Hanson Mouanoutoua's most frequent co-authors are Haifaa Abdulhaq, MD, Weiyun Z. Ai, MD and Charalambos I. Andreadis, MD.